Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- MYCureIndependent statistical analysis of Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- MYDAYISIndependent statistical analysis of Study of the Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early Evening: primary endpoint results, effect estimate with…
- myDExIndependent statistical analysis of Development of a Tailored HIV Prevention Intervention for Young Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02842060).
- MyDiaText Text Messaging Intervention for Diabetes: Complete Statistical AnalysisIndependent statistical analysis of MyDiaText Text Messaging Intervention for Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02927639).
- Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft: Complete Statistical AnalysisIndependent statistical analysis of Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Myeloablative Conditioning Orca-T & Allogeneic Donor-Derived CD19/CD22-CAR TCells in B-Cell ALL: Complete Statistical AnalysisIndependent statistical analysis of Myeloablative Conditioning Orca-T & Allogeneic Donor-Derived CD19/CD22-CAR TCells in B-Cell ALL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases: Complete Statistical AnalysisIndependent statistical analysis of Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00309842).
- MyFiIndependent statistical analysis of Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MYFIIRPIndependent statistical analysis of Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Mylan Insulin Aspart Study: Complete Statistical AnalysisIndependent statistical analysis of Mylan Insulin Aspart Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03760068).
- MyMenoPlan: Online Resource for Improving Women’s Menopause Knowledge and Informed Decision-making: Complete Statistical AnalysisIndependent statistical analysis of MyMenoPlan: Online Resource for Improving Women's Menopause Knowledge and Informed Decision-making: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Myoc GeneIndependent statistical analysis of Effect of Myocilin Genetic Variants on Intraocular Pressure and Pressure Variation in Sitting and Supine Positions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Myocardial Hemodynamic Effects of Levosimendan: Complete Statistical AnalysisIndependent statistical analysis of Myocardial Hemodynamic Effects of Levosimendan: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00585104).
- Myocardial Injury and Quality of Life After COVID-19: Complete Statistical AnalysisIndependent statistical analysis of Myocardial Injury and Quality of Life After COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04794062).
- myOpportunITy2Independent statistical analysis of A Study to Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP): primary endpoint results, effect estimate…
- myOpportunITy3Independent statistical analysis of A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP): primary endpoint results, effect estimate…
- MyoSure Hysteroscopic Tissue Removal System Registry Study: Complete Statistical AnalysisIndependent statistical analysis of MyoSure Hysteroscopic Tissue Removal System Registry Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01369758).
- MYPAICEIndependent statistical analysis of Mindfulness and Yoga for Pain With Interstitial Cystitis Evaluation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04820855).
- MyPathIndependent statistical analysis of Patient-Centered Reproductive Decision Support Tool for Women Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04584294).
- myPlanKenyaIndependent statistical analysis of Dissemination and Implementation of a Web-based Relationship Safety App, myPlanKenya, for Women at Risk for Intimate Partner Violence in Nairobi, Kenya: primary endpoint results, effect estimate with confidence…
- MYSTICIndependent statistical analysis of Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC): primary endpoint results, effect…
- MYTechIndependent statistical analysis of Me & You-Tech: A Socio-Ecological Solution to Teen Dating Violence for the Digital Age: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- N-3 PUFA and Rheumatoid Arthritis in Korea: Complete Statistical AnalysisIndependent statistical analysis of N-3 PUFA and Rheumatoid Arthritis in Korea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01618019).
- N-Acetyl Cysteine in Pathologic Skin Picking: Complete Statistical AnalysisIndependent statistical analysis of N-Acetyl Cysteine in Pathologic Skin Picking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01063348).
- N-Acetyl-L-Leucine for GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease): Complete Statistical AnalysisIndependent statistical analysis of N-Acetyl-L-Leucine for GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03759665).
- N-Acetyl-L-Leucine for Niemann-Pick Disease, Type C (NPC): Complete Statistical AnalysisIndependent statistical analysis of N-Acetyl-L-Leucine for Niemann-Pick Disease, Type C (NPC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03759639).
- N-acetylcysteine and NMDA Antagonist Interactions: Complete Statistical AnalysisIndependent statistical analysis of N-acetylcysteine and NMDA Antagonist Interactions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00611897).
- N-Acetylcysteine for Patients With COPD and Chronic Bronchitis: Complete Statistical AnalysisIndependent statistical analysis of N-Acetylcysteine for Patients With COPD and Chronic Bronchitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01739790).
- N-Acetylcysteine in Biliary Atresia After Kasai Portoenterostomy: Complete Statistical AnalysisIndependent statistical analysis of N-Acetylcysteine in Biliary Atresia After Kasai Portoenterostomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03499249).
- N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure: Complete Statistical AnalysisIndependent statistical analysis of N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00248625).
- N-acetylcysteine to Reduce Oxidative Stress and Improve Endothelial Function in HIV-infected Older Adults: Complete Statistical AnalysisIndependent statistical analysis of N-acetylcysteine to Reduce Oxidative Stress and Improve Endothelial Function in HIV-infected Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- N-ForceIndependent statistical analysis of N-Force Screws Augmented With N-Force Blue in Hip Fractures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03807349).
- N08HMEIndependent statistical analysis of Short-term Clinical Feasibility of the Provox XtraHMEs for Pulmonary Rehabilitation After Total Laryngectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- N30-005Independent statistical analysis of Pharmacokinetic Evaluation of Brisdelle™ (Formerly Known as Mesafem) Following Single & Repeat Oral Administration in Healthy Postmenopausal Women: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- N6 Input Processing in Traditional CI Recipients: Complete Statistical AnalysisIndependent statistical analysis of N6 Input Processing in Traditional CI Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02239263).
- Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA: Complete Statistical AnalysisIndependent statistical analysis of Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01893801).
- Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery: primary endpoint results, effect estimate with confidence…
- Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery: primary endpoint results, effect estimate with…
- Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas: Complete Statistical AnalysisIndependent statistical analysis of Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Nabilone in Cannabis Users With PTSD: Complete Statistical AnalysisIndependent statistical analysis of Nabilone in Cannabis Users With PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03251326).
- NABIS:HIIRIndependent statistical analysis of Effects of Hypothermia Upon Outcomes After Acute Traumatic Brain Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00178711).
- NACIndependent statistical analysis of Effectiveness of N-Acetylcysteine (NAC) in Treating Cocaine Dependent Individuals - 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NACIndependent statistical analysis of N-acetylcysteine Treatment of Alcohol Use Disorder In Veterans With TBI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02791945).
- NAC cold coughIndependent statistical analysis of Study to Evaluate the Efficacy of N-acetylcysteine (NAC) in the Treatment of the Common Cold and Cough: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- NAC MJ PilotIndependent statistical analysis of An Open-Label Trial of N-Acetylcysteine in Cannabis Dependent Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00542750).
- NAC Phase IIB: A Multi-Center, Phase IIB, Randomized, Placebo-controlled, Double-Blind Study Of The Effects Of N-Acetylcysteine On Redox Changes and Lung Inflammation In Cystic Fibrosis Patients: Complete Statistical AnalysisIndependent statistical analysis of NAC Phase IIB: A Multi-Center, Phase IIB, Randomized, Placebo-controlled, Double-Blind Study Of The Effects Of N-Acetylcysteine On Redox Changes and Lung Inflammation In Cystic Fibrosis Patients: primary endpoint…